Elamipretide

INN name:	Elamipretide
Lab codes:	MTP-131; SS-31
Alternative names:	Bendavia; Ocuvia
Chemical name:	D-arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-L-phenylalaninamide
Molecular formula:	C32H49N9O5
Chemical Structure:
CAS Registry Number:	736992-21-5
Originator:	Stealth Peptides
Developer:	Stealth BioTherapeutics
Mechanism of Action:	Cardiolipin peroxidase inhibitor
WHO ATC code:	A10 (Drugs Used in Diabetes) A16A-X (Various alimentary tract and metabolism products) C01 (Cardiac Therapy) G04 (Urologicals) M09A-X (Other drugs for disorders of the musculo-skeletal system) N07 (Other Nervous System Drugs) S01 (Ophthalmologicals) S01L (Ocular Vascular Disorder Agents) S01X-A (Other ophthalmologicals)
EPhMRA code:	A (Alimentary Tract and Metabolism) A10 (Drugs Used in Diabetes) C1 (Cardiac Therapy) G4 (Urologicals) M5 (Other Drugs for Disorders of the Musculo-Skeletal System) N7 (Other CNS Drugs) S1 (Ophthalmologicals) S1P (Ocular Antineovascularisation Products) S1X2 (Other Ophthalmologicals, Topical)
Clinical Trials: Indication Phase Status Reperfusion Injury;   STEMI Phase 2 Completed Skeletal Muscle Mitochondrial Dysfunction in the Elderly Phase 2 Recruiting Renal Artery Obstruction;   Hypertension, Renovascular;   Ischemia Reperfusion Injury Phase 1 / Phase 2 Recruiting Diabetic Macular Edema;   Age-related Macular Degeneration Phase 1 / Phase 2 Recruiting Mitochondrial Myopathy Phase 1 / Phase 2 Recruiting Heart Failure Phase 1 Not yet recruiting Normal and Impaired Renal Function Phase 1 Recruiting Congestive Heart Failure Phase 1 Recruiting
Product Patent Expiry: For patent data contact us at drugpatentexpiry@gmail.com